Carvalho T, Krammer F, Iwasaki A (2021) The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol 21:245–256. https://doi.org/10.1038/s41577-021-00522-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

World Health Organization (2024) WHO COVID-19 dashboard. In: WHO. https://data.who.int/dashboards/covid19/. Accessed 10 Mar 2024

Yang J, Zheng Y, Gou X et al (2020) Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94:91–95. https://doi.org/10.1016/j.ijid.2020.03.017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cdc Weekly C, The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) The epidemiological characteristics of an outbreak of 2019 Novel Coronavirus diseases (COVID-19) — China, 2020. China CDC Wkly 2:113–122. https://doi.org/10.46234/ccdcw2020.032

Article  Google Scholar 

Wiersinga WJ, Rhodes A, Cheng AC et al (2020) Pathophysiology, transmission, diagnosis, and treatment of Coronavirus disease 2019 (COVID-19): a review. JAMA 324:782. https://doi.org/10.1001/jama.2020.12839

Article  CAS  PubMed  Google Scholar 

Guan W, Ni Z, Hu Y et al (2020) Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa2002032

Article  CAS  PubMed  Google Scholar 

Hasenmajer V, Sbardella E, Sciarra F et al (2020) The immune system in Cushing’s syndrome. Trends Endocrinol Metabolism 31:655–669. https://doi.org/10.1016/j.tem.2020.04.004

Article  CAS  Google Scholar 

Feelders R, Sharma S, Nieman L (2015) Cushing’s syndrome: epidemiology and developments in disease management. CLEP 281. https://doi.org/10.2147/CLEP.S44336

Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335:2–13. https://doi.org/10.1016/j.mce.2010.04.005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623. https://doi.org/10.1016/j.beem.2009.06.001

Article  CAS  PubMed  Google Scholar 

Chanson P, Salenave S (2010) Metabolic syndrome in Cushing’s syndrome. Neuroendocrinology 92:96–101. https://doi.org/10.1159/000314272

Article  CAS  PubMed  Google Scholar 

Biering H, Knappe G, Gerl H, Lochs H (2000) Diabetes-haufigkeit bei akromegalie und cushing-syndrom. Acta Med Austriaca 27:27–31. https://doi.org/10.1046/j.1563-2571.2000.00106.x

Article  CAS  PubMed  Google Scholar 

Mazziotti G, Gazzaruso C, Giustina A (2011) Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol Metabolism 22:499–506. https://doi.org/10.1016/j.tem.2011.09.001

Article  CAS  Google Scholar 

Pivonello R, Isidori AM, De Martino MC et al (2016) Complications of Cushing’s syndrome: state of the art. Lancet Diabetes Endocrinol 4:611–629. https://doi.org/10.1016/S2213-8587(16)00086-3

Article  CAS  PubMed  Google Scholar 

Giordano C, Guarnotta V, Pivonello R et al (2014) Is diabetes in Cushing’s syndrome only a consequence of hypercortisolism? Eur J Endocrinol 170:311–319. https://doi.org/10.1530/EJE-13-0754

Article  CAS  PubMed  Google Scholar 

Scaroni C, Zilio M, Foti M, Boscaro M (2017) Glucose metabolism abnormalities in Cushing syndrome: from molecular basis to clinical management. Endocr Rev 38:189–219. https://doi.org/10.1210/er.2016-1105

Article  PubMed  Google Scholar 

Mancini T, Kola B, Mantero F et al (2004) High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol 61:768–777. https://doi.org/10.1111/j.1365-2265.2004.02168.x

Article  Google Scholar 

Kuo T, McQueen A, Chen T-C, Wang J-C (2015) Regulation of glucose homeostasis by glucocorticoids. In: Wang J-C, Harris C (eds) Glucocorticoid signaling. Springer New York, New York, NY, pp 99–126

Chapter  Google Scholar 

Nowotny HF, Bryce J, Ali SR et al (2023) Outcome of COVID-19 infections in patients with adrenal insufficiency and excess. Endocr Connections 12:e220416. https://doi.org/10.1530/EC-22-0416

Article  CAS  Google Scholar 

Magiakou MA, Smyrnaki P, Chrousos GP (2006) Hypertension in Cushing’s syndrome. Best Pract Res Clin Endocrinol Metab 20:467–482. https://doi.org/10.1016/j.beem.2006.07.006

Article  CAS  PubMed  Google Scholar 

Cicala MV, Mantero F (2010) Hypertension in Cushing’s syndrome: from pathogenesis to treatment. Neuroendocrinology 92:44–49. https://doi.org/10.1159/000314315

Article  CAS  PubMed  Google Scholar 

Isidori AM, Minnetti M, Sbardella E et al (2015) MECHANISMS IN ENDOCRINOLOGY: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur J Endocrinol 173:R101–R113. https://doi.org/10.1530/EJE-15-0308

Article  CAS  PubMed  Google Scholar 

Zilio M, Mazzai L, Sartori MT et al (2016) A venous thromboembolism risk assessment model for patients with Cushing’s syndrome. Endocrine 52:322–332. https://doi.org/10.1007/s12020-015-0665-z

Article  CAS  PubMed  Google Scholar 

Capatina C, Fleseriu M (2021) Thromboembolic disease in hypercortisolism. Curr Opin Endocrinol Diabetes Obes 28:330–336. https://doi.org/10.1097/MED.0000000000000630

Article  CAS  PubMed  Google Scholar 

Berlińska A, Świątkowska-Stodulska R, Sworczak K (2021) Old problem, new concerns: hypercortisolemia in the time of COVID-19. Front Endocrinol 12:711612. https://doi.org/10.3389/fendo.2021.711612

Article  Google Scholar 

Belaya Z, Golounina O, Melnichenko G et al (2021) Clinical course and outcome of patients with ACTH-dependent Cushing’s syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations. Endocrine 72:12–19. https://doi.org/10.1007/s12020-021-02674-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pivonello R, Ferrigno R, Isidori AM et al (2020) COVID-19 and Cushing’s syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol 8:654–656. https://doi.org/10.1016/S2213-8587(20)30215-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuno A, Kenmotsu Y, Takahashi Y et al (2021) Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia. Endocr J 68:477–484. https://doi.org/10.1507/endocrj.EJ20-0613

Article  CAS  PubMed  Google Scholar 

Blanco C, Marazuela M, Flores J, Alvarez J (2001) Severe respiratory failure secondary to Cushing’s myopathy. J Endocrinol Invest 24:618–621. https://doi.org/10.1007/BF03343903

Article  CAS  PubMed  Google Scholar 

Arnaldi G, Angeli A, Atkinson AB et al (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metabolism 88:5593–5602. https://doi.org/10.1210/jc.2003-030871

Article  CAS  Google Scholar 

Dekkers OM, Horváth-Puhó E, Jørgensen JOL et al (2013) Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J Clin Endocrinol Metabolism 98:2277–2284. https://doi.org/10.1210/jc.2012-3582

Article  CAS  Google Scholar 

Serban AL, Ferrante E, Carosi G et al (2021) COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy. J Endocrinol Invest 44:1335–1336. https://doi.org/10.1007/s40618-020-01419-x